Ö. YEDİKAYA Et Al. , "Nanostructured Lipid Carrier (NLC) Formulations of Paliperidone for Treatment of Schizophrenia ," 33rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2023) , Ankara, Turkey, 2023
YEDİKAYA, Ö. Et Al. 2023. Nanostructured Lipid Carrier (NLC) Formulations of Paliperidone for Treatment of Schizophrenia . 33rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2023) , (Ankara, Turkey).
YEDİKAYA, Ö., AMASYA, G., BADILLI, F. U., & ÖZDEMİR, A. N., (2023). Nanostructured Lipid Carrier (NLC) Formulations of Paliperidone for Treatment of Schizophrenia . 33rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2023), Ankara, Turkey
YEDİKAYA, ÖMER Et Al. "Nanostructured Lipid Carrier (NLC) Formulations of Paliperidone for Treatment of Schizophrenia ," 33rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2023), Ankara, Turkey, 2023
YEDİKAYA, ÖMER Et Al. "Nanostructured Lipid Carrier (NLC) Formulations of Paliperidone for Treatment of Schizophrenia ." 33rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2023) , Ankara, Turkey, 2023
YEDİKAYA, Ö. Et Al. (2023) . "Nanostructured Lipid Carrier (NLC) Formulations of Paliperidone for Treatment of Schizophrenia ." 33rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2023) , Ankara, Turkey.
@conferencepaper{conferencepaper, author={ÖMER YEDİKAYA Et Al. }, title={Nanostructured Lipid Carrier (NLC) Formulations of Paliperidone for Treatment of Schizophrenia }, congress name={33rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2023)}, city={Ankara}, country={Turkey}, year={2023}}